Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

  • M S Fernández‐Alfonso
    Instituto Pluridisciplinar and Facultad de Farmacia Universidad Complutense Madrid Spain
  • M Gil‐Ortega
    Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia Universidad CEU‐San Pablo Madrid Spain
  • I Aranguez
    Instituto Pluridisciplinar and Facultad de Farmacia Universidad Complutense Madrid Spain
  • D Souza
    Department of Cardiothoracic and Vascular Surgery and University Health Care Research Center, School of Medical Sciences Örebro University Örebro Sweden
  • M Dreifaldt
    Department of Cardiothoracic and Vascular Surgery and University Health Care Research Center, School of Medical Sciences Örebro University Örebro Sweden
  • B Somoza
    Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia Universidad CEU‐San Pablo Madrid Spain
  • M R Dashwood
    Royal Free Hospital Campus University College Medical School London UK

抄録

<jats:sec><jats:label /><jats:p>Perivascular adipose tissue (PVAT) releases numerous factors and adipokines with paracrine effects on both vascular structure and function. These effects are variable as they depend on regional differences in PVAT among blood vessels and vary with changes in adiposity. There is considerable evidence demonstrating an association between coronary PVAT and the development and progression of coronary artery disease, which is associated with inflammation, oxidative stress, angiogenesis, vascular remodelling and blood clotting. However, PVAT also has a protective role in vascular grafts, especially the no‐touch saphenous vein, in patients undergoing coronary artery bypass. This beneficial influence of PVAT involves factors such as adipocyte‐derived relaxing factor, nitric oxide (NO), leptin, adiponectin, prostanoids, hydrogen sulphide and neurotransmitters, as well as mechanical protection. This article aims to highlight and compare the dual role of PVAT in the development and progression of coronary atherosclerosis, as well as in increased graft patency. Different deleterious and protective mechanisms of PVAT are also discussed and the inside‐outside signalling paradigm of atherosclerosis development re‐evaluated. The bidirectional communication between the arterial and venous wall and their surrounding PVAT, where signals originating from the vascular wall or lumen can affect PVAT phenotype, has been shown to be very complex. Moreover, signals from PVAT also influence the structure and function of the vascular wall in a paracrine manner.</jats:p></jats:sec><jats:sec><jats:title>Linked Articles</jats:title><jats:p>This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue – Potential Pharmacological Targets? To view the other articles in this section visit <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc">http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc</jats:ext-link></jats:p></jats:sec>

収録刊行物

被引用文献 (8)*注記

もっと見る

キーワード

問題の指摘

ページトップへ